Potentially deadly staph bacteria may be easily defeated by the body's own immune system once stripped of their golden hue by a drug developed to lower cholesterol, according to new research.The findings offer a promising new direction in the fight against increasingly drug-resistant staph infections, according to the National Institutes of Health, which supported the research. An international team of researchers found that a "squalene synthase inhibitor," originally developed by Bristol Myers Squibb, blocks infections of Staphylococcus aureus, named for its "golden halo," in mice.Staph contains a carotenoid -- like beta carotene in carrots -- that acts like an antioxidant...